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Abstract
Introduction: Post-operative scarring process on lumbar surgery is 
object of several studies mainly because of the epidural fibrosis 
formation. Chitosan have shown promising effect fibrosis prevention. 
The aim of this study is to determine the influence chitosan-silane 
membrane on the lumbar surgery scarring process. These membranes 
have improved mechanical strength which makes it suitable to mantain 
a predefined shape. 
Materials/methods: Fourteen New Zealand male rabbits underwent 
two level lumbar laminectomy. Laminectomy sites were randomly 
selected for biomaterial or control. Chitosan membranes were 
prepared and care was taken in order to make it adapted to the bone 
defect dimensions in a way that it covered the totality of the defect 
and also the bone margins. Histological analysis was performed by 
haematoxylin/eosin and by Masson’s trichrome staining four weeks 
after laminectomy.
Results: Microscope observations revealed the presence of a well-
organized regenerating tissue, integrated in the surrounding vertebral 
bone tissue with a regular and all-site interface on the chitosan sites, 
in clear contrast with the presence of a disorganized regenerating 
tissue with aspects consistent with the persistence of a chronic 
inflammatory condition, on control sites.
Conclusions: The results of this study clearly demonstrated that 
chitosan had an organizing effect on post-operative scarring process. 
The presence of the chitosan membrane resulted on a well-organized 
tissue integrated in the surrounding vertebral bone tissue with signs of 
regenerative bone tissue in continuity with native bone. This can be a 
major feature on the dynamics of epidural fibrosis formation.
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Lumbar disk herniation
The sciatic  pain, which is pain radiating from the lumbar region to 
the inferior limb, is a condition previously described in ancient Rome 
and Greece manuscripts, although not associated with a spine disorder. 
In fact, the intervertebral disc  was described much later, by Vesalius, 
in 1555. In 1764, Cotugno established an association between sciatic 
pain and the sciatic  nerve and 15 years later, Pott established a 
relationship between this type of pain and a spine disorder. It's only in 
1858 that Luschka, based on autopsy studies, observed and registered 
degenerative disc processes. In the early years of the XX century, 
several authors have proposed an association between sciatic pain and 
lumbar disc herniation (Sachs and Fraenkel, 1900; Bailey and 
Casamajor, 1911; Goldthwait, 1911) but without major acceptance. 
This perspective have changed in 1929 when the first case was 
presented by Dandy and, in 1934, Mixter and Barr cleared its 
pathophysiology on a 34 cases review. (1,2,3,4,5)
In these pioneer times, the surgical procedure proposed by Mixter 
and Barr involved a wide removal of the vertebral laminae and a 
discectomy throughout an intradural approach. It was in 1977 that, not 
only Yasargil, in Switzerland, as Caspar, in Germany, described 
microdiscectomy surgical techniques, by an extradural approach, and 
using the surgical microscope. (4,6)
Meanwhile, the acquired clinical experience led to the 
identification of additional factors enrolled on the sciatic pain 
pathogeny. Therefore, it's currently assumed that the pulpous nucleus 
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has a local sensitizing effect on the nerve and the pain is triggered by 
the local deformity induced by the herniation. (5)
Currently, as the disc  herniation sciatic pain not associated with 
neurological deficits is a benign condition, that could resolve 
spontaneously, the therapeutic approach is usually initiated with 
conservative treatment, reserving surgery for selected cases. (7)
Lumbar discectomy
Actually, the lumbar discectomy is the most common neurosurgical 
procedure performed in the US, with about 300.000 lumbar 
discectomies being performed each year. This is a direct result of the 
near 15 million medical consultations for lumbar pain each year, 
together representing a direct and indirect cost of over US$ 50 billion, 
per year. (4)
The surgical technique for lumbar discectomy is performed under 
general anaesthetics, with the patient on a ventral decubitus position, 
with care taken to avoid pressure over the abdomen in order to 
minimise the epidural haemorrhage (which would be profuse if there is 
an elevated venous pressure). The patient hips and knees should be 
flexed in order to provide posterior distraction of the interdisc space. 
The skin incision is performed longitudinally, on the midline and to the 
level of the dorsolumbar fascia. (1,2,4,8)
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A 10-12 cm long skin incision is suggested by Benzel that argues that 
a wider approach as the advantage of, among others, inducing less 
trauma to the paravertebral muscles. (2)
However, Javedan and Sonntag suggested shorter skin incisions that 
should variate arround 3 to 6 cm long and Koebbe et al. suggested 
even shorter skin incisions from 1,5 to 2,5 cm long. (4,8)
After the division of the subcutaneous fat and identification of the 
dorsolumbar fascia, the latter is divided laterally to the spinous 
process in order to preserve the interspinous ligaments. The 
paravertebral muscles are then separated from the bone through 
subperiosteal dissection and division of the ligaments inserted on the 
inferior edge of the cranial vertebra. From this stage on, most of the 
authors recommend the use of the surgical microscope; however, 
Benzel does not use it in his description of the standard discectomy 
technique.
Then begins the stage of bone removal which starts by the inferior 
edge of the superior hemilamina in its most medial portion, which is 
where the canal has it's maximum diameter, therefore minimizing the 
risk of lesion of the intracanalar structures. The bone removal extends 
laterally on the inferior edge of the cranial hemilamina with exposure 
of the ligamentum flavum. This ligament has insertions on the inferior 
edge and intracanalar surface of the cranial lamina therefore 
separating the lumbar dura from the plane of bone manipulation, 
minimising the risks of dural lesion. In this stage the bone removal 
have provided a comfortable space for opening of the ligamentum 
flavum. After removal of the exposed ligmantum flavum, its rostral 
insertions should be removed together with a bone rim. (1,2)
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Performed this way, the opening of the vertebral canal should be 
about 20-25 mm long on the longitudinal axis and 10-15mm on the 
transverse axis. Such a window would be wide enough to allow a clear 
visualization of the tecal sac and the nerve root and would permit 
mobilization of these structures to the approach of the interdiscal 
space. During the bone and ligament removal, the handling of the 
epidural fat should be performed with great caution. The preservation 
of this tissue is considered of great importance because it could be 
protective against the perineural fibrosis formation. (1,2)
Before the nerve root medial mobilization to allow the approach to 
the intervertebral space, an ipsilateral foraminotomy should be 
performed in order to add space to the mobilization of the nerve root 
with minimal stretching. (8) 
After the medial retraction of the nerve root it could be visualized 
herniated fragments which should be removed in order to expose the 
intervertebral space. The posterior longitudinal ligament and the 
annulus should be divided in order to proceed to the removal of the 
nucleus pulposus. After this removal, any epidural bleeding should be 
controled with bipolar coagulation or haemostatic agents. (1,2,8)
The closure will include suture of the dorsolumbar fascia, 
subcutaneous layers and skin. (1,2,4,6,8,9)
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Lumbar surgery outcome
The lumbar disk surgery estimated success rates are between 49 and 
90% with a reintervention rate of 4 to 15%.(10,11) On the retrospective 
study of 654 patients who underwent surgery on the Barrow 
Neurological Institute, Pappas et al. reported good/excellent surgical 
outcomes in most of the patients with a reintervention rate of 11% and 
with 3% of local relapse of lumbar disk herniation. The surgical 
technique described by the authors included the disk removal aside 
from the extruded fragment. The technique proposed by Williams, 
with exclusive removal of the herniated fragment had about 9% of 
relapse rate, against the 4% rate described by Yasargil and Caspar with 
radical disk removal and curettage of the vertebral plates. In the study 
performed by Pappas et al. there was no significant difference on the 
outcome of patients who underwent placement of fat graft after 
discectomy against those who underwent simple discectomy.(12)
On a 1996 paper, Fritsch et al. retrospectively evaluate 182 cases of 
FBSS lumbar surgical reinterventions and, reporting a post-discectomy 
reintervention rate of 10,8%, conclude that instability and epidural 
fibrosis are the most contributive factors to poor results and 
reinterventions related to lumbar disk surgery.(13)
Ambrossi et al., on a retrospective study of 156 consecutive patients 
who underwent surgery for lumbar disk herniation, at the Johns 
Hopkins Hospital, reported that 88% of patients had no symptoms or 
minimal symptoms which do not prevented their daily activities, at 1-
year follow-up. They also reported 12% of patients with local relapse 
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of lumbar disk herniation. Of these 17 patients, 11 needed a second 
surgical intervention with an estimated cost of $39.836 USD vs. $2.315 
USD for the 6 patients who underwent conservative treatment.(14)
Abramovitz and Neff, on the first prospective study designed to 
evaluate the outcome of lumbar disk surgery, reported 78,7% of good 
results at 3 months follow-up (with 19,2% of medium and 2,1% of poor 
results) and 79,3% of good results at 1 year follow-up (with 16% of 
medium and 4,7% of poor results). The authors argued that those 
results are related directly to a thorough patient selection. To 
illustrate this statement they point out the positive association 
between purely radicular pain and good surgical results and its 
negative association with predominantly axial pain. These authors 
relevance the patient’s psychological evaluation, pointing it as a factor 
that will influence the surgical results.(15)
The patient psychological evaluation, albeit thorough, has no 
capability of surgical outcome prediction. However patients with the 
best surgical outcomes are mostly stable, cautious, defensive, 
confidant, with realistic concerns about their condition, could be 
mildly depressive but optimistic to the surgical outcome and with 
abilities to deal with setbacks. The patients with poorer surgical 
outcomes are less sable, unpredictable, depressive and with less 
ability to deal with stress and setbacks.(16)
These results, raised the debate over the role of surgery in the 
treatment of this condition. The SPORT trial (Spine Patient Outcomes 
Research Trial) is a prospective, multicentric, randomised study, in 
which the 2008 update gave advantage to surgical over conservative 
treatment (with 4 year follow-up) not only on pain relive but also on 
functional recovery. In this trial, the patients enrolled to the surgical 
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group were patients with pain lasting from two or more months and/or 
neurological deficit. The authors registered a post-discectomy 
recurrent disk herniation rate as high as 7% and a re-operation rate of 
11%.(17)
Failed Back Surgery Syndrome
The so called Failed Back Surgery Syndrome (FBSS) it's a nonspecific 
condition that translate a surgical result that do not meet the 
expectations established before the surgery, nor for the patient, 
neither for the surgeon.(18) Therefore, its etiology could be related to 
poor criteria of patient selection, misdiagnosis, and a suboptimal 
selection of the surgical approach, poor surgical technique, and 
impossibility of achievement of the surgical goals and/or recurrent 
pathology.(19,20) 
The structural causes of this syndrome could be identified in about 
90% of the patients by complementary means. The most common 
causes of FBSS are the foraminal stenosis (25-29%), discogenic pain 
(20-22%), pseudarthrosis (14%), neuropathic pain (10%), recorrent 
lumbar disk herniation (7-12%), iatrogenic instability (5%), facet pain 
(3%) and sacro-iliac  joint pain.(18,20,21) Waguespack et al. report similar 
causes for FBSS but they point out psychological problems as a cause 
of 3% of FBSS.(21)
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The presence of epidural fibrosis is described in about one third of 
the patients following lumbar disk surgery.(10) However, the 
relationship between epidural fibrosis present on imaging post-
operative studies and patients complaints is not entirely clear. Cinotti 
et al., on a lumbar disk surgery reoperation study had not found a 
clear relation between the amount of epidural fibrosis and the 
outcome of reoperations.(22) Nevertheless, the presence of epidural 
fibrosis is considered to be related with a poor surgical outcome for 
FBSS repeated surgeries. North et al. report a good outcome for those 
patients who do not present with post-operative epidural fibrosis in an 
amount that would indicate a reoperation.(10,20)
The epidural fibrosis after lumbar discectomies consists on a 
replacement of the normal epidural fat layers by post-operative 
fibrotic tissue. This fibrotic tissue enhances dura-mater and nerve root 
adhesions to the surrounding tissues, being the nerve changes resulting 
from those adherences pointed out, theoretically, as the main 
mechanism for recurrence of radicular pain following lumbar 
discectomy.(23,24)
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Post-operative healing
The FBSS etiology is not clearly understand and local relapse of disk 
herniation and post-operative epidural fibrosis are pointed as the 
leading causes of this syndrome. The epidural fibrosis development 
after lumbar laminectomy is an unavoidable event and it develops 6 
weeks to 6 months after surgery. The epidural fibrosis pathogenics is 
not fully cleared however, it's commonly accepted that the remaining 
debris on the surgical site, act as fibrotic stimuli.(25)
According LaRocca and Macnab, the membrane formed after 
laminectomy would be the result of the destruction of the epidural 
fat, surgical site hematoma and of the penetration of paravertebral 
muscles on the vertebral canal. The hematoma, present on the 
surgical site would be gradually absorbed and replaced by granulation 
tissue. The granulation tissue maturation would result on the fibrotic 
epidural tissue.(26)
Therefore, the epidural fibrosis is the result of post-operative 
hematoma invasion by thick fibrotic tissue, starting on the periosteum 
fibrous layer and fibroblast migration from the deep layer of the 
paravertebral muscles. This process can progress to the vertebral canal 
and create adherences to the dura-mater and nerve roots.(27,28) The 
fibrosis formation creates adherences that fix the root in the lateral 
recess and make it more sensitive to compressive or tension forces or 
to isquemia which would be, otherwise, assymptomatic. The factors 
included in the formation of perineural fibrosis include the amount of 
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trauma inflicted to the soft tissues during surgery and the amount of 
blood collected on the surgical site.
The epidural fibrosis could be associated to tissue damage processes 
mediated by inflammation and cellular adhesion molecules. The 
cellular adhesion molecules have been involved on the adhesion or 
scar tissue formation on the pathogenesis of some diseases, such as 
pulmonary fibrosis. In this context, there is some cellular adhesion 
molecules upregulation on the sites of active disease which promotes 
leucocyte recruitment and activation. The interaction between 
leucocytes and pulmonary parenchymal cells (and not the amount of 
inflammatory cells) will determine the pulmonary fibrosis formation.
(29)
To test this hypothesis on the context of post-laminectomy epidural 
fibrosis, Sabuncuoglu et al. used monoclonal antibodies against 
intercellular adhesion molecule 1 and it's ligand, CD-18, on an 
experimental laminectomy model. They reported, with this strategy, 
an epidural fibrosis reduction on the treated animals.(30)
As appealing as this hypothetical model could be, some studies 
suggested that epidural fibrosis would be considered as a radiological 
entity without relationship with patient's complaints.(25,31)
In 1996, Ross et al. presented a prospective, randomized, 
controlled, blind and multicentric trial of 197 patients with a 
significative association between epidural fibrosis and recurrent 
radicular pain. However, this study presents some curious data. It is 
important to realise that only a fraction of patients who had severe 
fibrosis (19,4%) had recurrent radicular pain and, on the other hand, 
6% of patients with less extensive epidural fibrosis, had recurrent 
radicular pain.(23)
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The prevention of post-operative perineural fibrosis has been object 
of increasing interest as this condition has been pointed out has one of 
the main causes of lumbar surgery failure, commonly known as Failed 
Back Surgery Syndrome. 
Therefore, it would be expected that a more minimalist and 'clean' 
surgery (concerning a thorough removal of the ligamentum flavum 
debris during fenestration and an effective haemostasis during 
closure), would have better outcomes.
Surgical options
For the therapeutic approach to lumbar degenerative disease, 
especially lumbar disk herniation, many treatment modalities were 
described in the early years of the 20th century. The first surgical 
technique description for lumbar disk herniation belongs to Mixter and 
Barr, in 1934.
On the attempt to minimize the exposure of soft tissues for the 
lumbar discectomy, Yasargil, in 1977 and Caspar and Loew in 1978, 
described microsurgical techniques with the objective of minimize the 
skin incision, the surgical trauma to paravertebral muscles and nervous 
structures and allow a better visualization of the intervertebral space 
with the surgical microscope.(32)
Javedan and Sonntag suggested the preservation of the medial 
portion of the ligamentum flavum in order to protect the intracanalar 
structures against post-operative scarring. On the technique described 
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by those authors it's not recommended the preservation of the 
epidural fat layer.(8)
There are descriptions of more minimalist approaches with minimal 
bone, ligamentum flavum and/or epidural fat removal, as the 
technique described by Williams.(6)
Facing the concern with FBSS, Williams developed the technique of 
microsurgical exclusive removal of the disk fragment responsible for 
the nerve root compression. He assumed that a more conservative 
approach would prevent most of the problems associated to the FBSS 
(epidural fibrosis, discogenic pain, spondilosis, arthrosis and 
instability). Williams recommend a minimal removal of bone, 
ligamentum flavum and epidural fat and he called this approach a 
sequestrectomy. It's postulated that the fibrous annulus opening from 
where the nucleous pulposus herniated, would close spontaneously. 
The literature about this technique reports 86-97% success rates.(6)
On a recent meta-analysis of the published series comparing 
sequestrectomy and conventional discectomy, it's reported that, on 
long-term, conventional discectomy presents with a higher incidence 
rate of lumbar pain and recurrent sciatic  pain and, on the other hand, 
sequestrectomy presents with a higher incidence of recurrent lumbar 
disk herniation.(33)
Other authors have proposed small changes to the surgical 
technique with the goal of diminishing post-operative epidural fibrosis 
formation. Several authors described ligamentum flavum preserving 
techniques believing that, preserving this anatomical plane, it would 
act as a barrier to fibrosis formation and epidural adherences. (9,34,35,36)
The ligamentum flavum is the ligamentous structure which contains 
the highest percentage of elastic fibers of all human tissues. In 
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addition to its biomechanical properties, it physically covers the dura-
mater, the nerve root, the epidural fat, acting as a protective barrier 
for those structures. The results for this type of surgery are similar to 
those of standard discectomy with less post-operative epidural fibrosis 
and with more easiness in a second surgery when needed.(9,34)
Oktenohlu et al. describe a technique of preservation of the 
ligamentum flavum with evidence of reduced local post-operative 
fibrosis at 6-months follow-up. On this technique, the authors propose 
a circunferencial incision in the ligamentum flavum forming a small 
flap that would be sutured into its position after the diskectomy was 
performed.(9)
The ligamentum flavum could be responsible for the development of 
perineural fibrosis when it's not fully removed during the surgical 
procedure and remnants persist under the lamina. Therefore, Benzel 
resumes the approach to the ligamentum flavum in two distinct 
options: minimal fenestration with near total preservation of the 
ligament or, complete removal, insisting on the thorough removal of 
the ligament under the rostral lamina, on the lateral recess and on it's 
inferior insertion, which is on the superior edge of the inferior lamina.
(2)
The epidural fat is histologically different from the subcutaneous 
fat. The histological studies performed by Wolfram-Gabel et al., 
describe the epidural fat as a tissue composed by a homogenous 
adipocyte population (concerning shape and size) with a minimal 
amount of connective tissue. These characteristics are in contrast with 
those of the subcutaneous fat in which the adipocytes have different 
sizes and shapes and there are bundles of connective tissue that 
subdivide this layer in lobules. Despite all these differences the 
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distinctive feature of the epidural fat is the presence of empty spaces 
with a special arrangement.  
These empty spaces would divide the epidural fat in several layers 
allowing each layer to slide over the adjacent ones and this 
characteristic earned the denomination of 'sliding spaces' from the 
authors. Therefore, the histological features of the epidural fat 
explain its semi-fluid characteristic  and confirm its specificity. Its 
localization, at the level of the lumbar spine mobile segment (on 
adults, since on fetuses these tissue is uniformly distributed, 
surrounding the entire dural sac), suggests that this structure has an 
important role on the interface between the posterior surface of the 
dural sac and the bony-ligamentous structures forming the posterior 
wall of the vertebral canal.(37)
Therefore, the absence of the fat epidural tissue after lumbar 
surgery and the formation of epidural fibrosis could lead to 
compression and/or adhesion of the nervous structures. This is the 
main reason for, as said before, the recommendations of great care 
handling the epidural fat tissue during lumbar surgery.
Minimally Invasive Spine Surgery
On the field of minimally invasive discectomy, the first steps were 
given by Lyman Smith who, in 1963, injected a chemical agent, 
percutaneously, on the disk space with the objective of nucleous 
pulposus destruction. This was a papain-derived chemical agent which 
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gain the designation of 'chymopapain' and it's role on the dissolution of 
the nucleous pulposus had been previously observed by the author on 
experimental studies using a rabbit model. This process, known as 
chemical nucleolisis, was abandoned, mainly, because of its high rate 
of serious complications (anaphylactic reactions) and because it's 
efficacy was inferior to the standard discectomy. (38,41)
About a decade later Hijikata, in Japan, described a technique of 
manual percutaneous nucleotomy which consisted on the removal of 
the nucleous pulposus through a working tube placed on the disk space 
percutaneously. This process had the objective of reducing the intra-
disk pressure with the following reduction of the irritative effect over 
the nerve root and fibrous annulus and peridisk area pain receptors. 
After successive changes and improvements of the technique and 
despite the high success rates observed (similar to the standard 
discectomy), these techniques are not used commonly because, 
mainly, the impossibility to approach the lateral recess and perform 
foraminotomy and the impossibility, on a high percentage of cases, to 
access the L5-S1 disk space percutaneously. (39,41)
In the mid-eighty's Gary Onik proposed an automated percutaneous 
lumbar diskectomy using a probe with simultaneous suction and 
cutting function. This technique also was of inferior efficacy to the 
standard diskectomy and it was contraindicated on patients with 
extruded hernia fragments (about 70% of the technique related 
failures was related with hernia fragments not visualised on the pre-
operative imaging). The laser diskectomy technique was also used on 
the eighty's with very satisfying results but not superior to the results 
achieved with the standard diskectomy.(40,41)  
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The endoscopic diskectomy is a promising technique with some 
advantages over the other minimally invasive diskectomy techniques 
because it allows the approach and the direct visualisation of the disk 
and the nerve root compression. However, there are limited 
advantages over the standard diskectomy and it has a flat learning 
curve by which it's a low popularity approach.(40,42,43)
Endoscopic techniques are also under development for the 
treatment of FBSS, specially the endoscopic  adhesiolisis, which allows 
either the local drug administration.(44)
Other strategies
Several materials have been studied with the goal of prevention of 
epidural fibrosis and it's complications, such as autografts (free and 
pedicled fat tissue grafts and repositioning of the ligamentum flavum), 
biomaterials used as mechanical barrier (polytetrafluoroethylene 
membranes, Gelfoam, Silastic membranes, Surgicel, Avitene, 
polymethyl methacrylate, carbon hydrates based synthetic  polymers 
and Goretex), topical application of drugs for fibroblast function and 
infiltration reduction (urokinase, tissue plasminogen activator, 
mitomycin C, hyaluronic acid and glucocorticoids), intra-operative 
application of CO2-laser therapy and localized external-beam 
radiotherapy application peri-operativelly. (45,46,47,48,49,50,51,52)
A thorough hemostasis is suggested to avoid epidural fibrosis 
formation. Several approaches have been proposed for this purpose. 
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An absorbable gelatine sponge was tested and it was reported that it 
acted as a stimulus to fibrosis production and therefore it's use is 
unadvised.(2,45)
The platelet-derived growth factor (PDGF) is a mitogenic agent 
responsible for the migration and proliferation of miofibroblasts and 
which could have an important role on the epidural fibrosis formation 
within the local post-discectomy hematoma. Therefore, the prevention 
of hematoma formation on the surgical site is of extreme importance. 
The tissue reparation requires the fibrin removal either by leucocytic 
phagocytosis, as by fibrinolysis mediated by local release of 
plasminogen activator. Those hypothesizes are supported by the report 
of decreased fibrotic tissue formation with local application of 
recombinant tissue plasminogen activator (rt-PA), on animal models.(46)
Ceviz et al., on an experimental animal model, tested uroquinase 
on the prevention of peridural fibrosis assuming that this enzyme, 
acting on the surgical site, would accelerate the degradation of the 
hematic  debris. Therefore, the authors verified an uroquinase epidural 
fibrosis preventive effect confirming the important role of the surgical 
site hematic debris for the fibrosis formation.(47)
The use of free fat grafts it's commonly utilized by spine surgeons. 
The rationale for the use of free fat grafts on the laminectomy site 
over the dura-mater is that it could reduce the epidural fibrosis and 
allow a better interpretation of post-operative imaging.(31) The effect 
of this technique is, however, questionable. The fat grafts besides 
producing a mass effect, they shrink over time, there are descriptions 
of fibrotic adherences between the graft and the dura-mater (probably 
with origin on a graft surounding hematoma) and a foreign body 
reaction itself could promote fibrosis and adherences. In addition to 
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those factors, it is almost impossible, technically, to apply the fat 
graft in the entire nerve root circumference.It has been reported some 
cases of graft displacement associated with neurological deficit. On 
the other hand, it was described that there is a reduction of the graft 
volume over time, presenting, over a year, with about 30% of its initial 
volume. Other complications associated to fat grafts are: fat graft 
inflammation and aseptic necrosis.(45,48,49)
One of the most popular gestures used with the objective of 
peridural fibrosis prevention is the topical application of steroids even 
though without clinical evidence based on scientific studies. The 
benefit of the topical steroid application was achieved on animal 
experimental models. However, some controversial results are 
published and there are reports on scaring delays and of frequent 
abscess formation.(50)
The Aloe Cepea extract, or 5-ureo-hidantoin, is a natural molecule 
derived from the onion with bactericidal and anti-inflammatory 
effects. The mix used by Temiz et al., on animal models, was effective 
on the reduction of epidural fibrosis with no inhibition of bone repair. 
Besides, it's a cheap material, liable to sterilization procedures and of 
easy applicability.(51)
Radiotherapy has been used on clinical practice to prevent post-
operative keloid scar recurrence since the fifties. Radiation reduces 
fibroblasts proliferation which prevents keloid scaring formation. 
Radiotherapy as also been tested on heterotopic bone growth 
prevention after total hip replacement.
The ionizing radiation radiobiological target seems to be pluripotent 
mesenquimal and radiosensitive cells which have a stimulus to 
proliferation and differentiation due to a specific  trauma, such as 
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surgery. Gerszten et al. verified an epidural fibrosis reduction, on 
experimental models, using a 700 cGy single dose administered 
through an 6 MeV electron beam performed before, during or after a 
laminectomy procedure.(52)
Also on experimental models, it has been verified that the 
radiotherapy inibitory effect over epidural fibrosis formation would be 
similar to the application of a Goretex membrane.(45)
However, when using radiotherapy one should be aware of its 
adverse effects, specially it's direct effect on the surgical wound 
repair (local erythema, suture dehiscence, hematoma or infections) 
and the risk of neoplastic lesions on the long run.(45,52)
The ideal agent for epidural fibrosis and adhesions prevention 
should have, therefore, the following characteristics: 1) Scar tissue to 
dural structures adhesions preventive effect; 2) leptomeningeal 
arachnoiditis preventive effect; 3) No effect on dural repair when it is 
lacerated with CSF leakage; 4) No inflammatory induction effect on 
perineural tissues.(53) 
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Biomaterials used for enhancing post-operative healing
The Adcon-L, a gelatine hydrocarbonated polymer has proven to be 
effective on the reduction of perineural fibrosis, not only on 
histological animal studies as on human radiological studies. 
In the late nineties it was tested the Adcon-L (Gliatech, Cleveland, 
OH, USA), an animal origin substance, absorbable, with a biological 
life of 6 weeks and which had demonstrated a significative reduction 
of scar tissue formation on animal models.(54)
This effect was equally demonstrated on human trials, 6 and 12 
months post-surgery. In addition to this, on clinical trials, the patients 
treated with Adcon-L (Gliatech, Cleveland, OH, USA) showed a 50% 
improvement on activity related pain scores, compared with 37% 
improvement on control group.(55,56)
Adcon-L (Gliatech, Cleveland, OH, USA) become, therefore, the 
most promising material for epidural fibrosis prevention however, it 
was withdrawn from the market due to multiple CSF fistulas human 
reports, due mainly to a diminished capacity of dural repair when 
ADCON-L is used. It was also suggested that this compound would 
interfere with bone regeneration which could impair fusion.(53,57)
This biomaterial is applied all-around the nerve root.(54)
On animal models it was also tested the hialuronic acid which is 
used currently in other surgical fields with the objective of fibrosis 
reduction. The local use of high molecular weight hialuronic  acid has 
shown to reduce the post-laminectomy epidural fibrosis formation, on 
an experimental study with an animal model. The authors suggested 
this use based on the fact that the fetal lesion repair doesn't have any 
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scar tissue involved, during the first two quarters of pregnancy.(58,59) 
The fetal lesions repair occurs through an extracellular matrix which 
creates an unique environment in which the key condition is the 
presence of high molecular weight hialuronic acid. The fetal tissue 
repair matrix also has low concentrations of hialuronidase and beta 
tumoral growth factor. These authors verified that the use of barrier 
materials was more effective on the post-surgery epidural fibrosis 
formation than the use of high molecular weight hialuronic acid or the 
gel form ADCON-L, on the surgical site.(58,59,60) However, the use of 
bone wax, synthetic membranes (as, for example, silastic) or fascia 
grafts were also tested, but it's use is not recommended because it 
was not verified, on clinical trials, a preventive effect for post-
operative residual nerve root pain.(2)
Some authors, based on the use of heparin embedded collagen 
membranes for the prevention of post-laparoscopy intra-peritoneal 
adherences, have used this material on laminectomy experimental 
models. Temiz et al used a mixture of heparin, alantoin and Aloe cepea 
extract. The alantoin is known by its supportive effects on primary and 
secondary scaring processes.(51)
The polilactid resorbable film is used on clinical practice with the 
objective of preventing soft tissue adherences to visceral structures. 
Studies conducted by Klopp et al. and by Welch et al. showed that this 
material reduce epidural fibrosis and does not interfere with dural 
repair.(53)
It was verified that polyehtylene oxide and carboxymethylcellulose 
membranes prevented the formation of peritoneal adherences on 
animal models. Rodgers et al. tested that compound (Oxiplex; 
FzioMed, Inc., San Luis Obispo, CA), under a gel and membrane forms, 
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on animal laminectomy models verifying the same preventive effect on 
the epidural fibrosis and adherences formation, in the gel and 
membrane forms.(57)
Kim et al. tested the Oxiplex/SP gel composed of polyethylene 
oxide and carboxymethylcellulose. Pre-clinical studies showed that the 
carboxymethylcellulose reduced adhesion and epidural fibrosis 
formation. The polyethylene oxide, on is turn, interacted with proteins 
that, when organised, contribute to fibrosis formation. Based on 
favourable experimental results, these researchers conducted a blind, 
randomized, multicentric pilot clinical study with evidence of clinical 
benefit from the use of this biomaterial on 6 and 12 months follow-up.
(61)
The use of a vicryl mesh was tested and got good results. Superior 
results were achieved when using a Goretex membrane. This is a very 
thin membrane (0,1mm thick), malleable, synthetic, biocompatible 
and non resorbable. This membrane presents two functionally distinct 
surfaces: one surface with texture due to 22 micron pores and a flat 
surface with small 3 micron pores which minimizes tissue adherences. 
Alkalay et al. have tested bioelastic, biosynthetic  polymers 
successfully demonstrating its safety and efficacy on epidural fibrosis 
reduction, on animal models. Those authors also underline the 
importance of an accurate application of the material, overlapping the 
membranous material over the laminectomy bony limits in order to 
achieve a total filling of the bone defect which would prevent the 
penetration of fibrotic tissue on the vertebral canal.(27)
Akeson et al., based on post-laminectomy epidural fibrosis animal 
models, suggested that the application of a high molecular weight 
hyaluronic acid gel or the interposition of a Goretex membrane over 
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the bony defect would have similar effects on the post-operative 
fibrosis and adherences formation. The authors discourage the 
application of membranes inside the vertebral canal, over the dura-
mater, and suggest it's application over the laminectomy borders. The 
membrane itself would lead to the formation of fibrotic tissue in order 
to form an envelope involving it and not in the vertebral canal.(60)
However, several studies stress that the most effective strategy 
would be the interposition of a barrier, based on collagen 
quantification studies, on experimental models.(58,59)
Kim et al. using the high molecular weight hyaluronic acid (Healon; 
Pfizer, Inc., New York, NY) epidural fibrosis preventive features have 
studied the behaviour of mice after laminectomy with Healon 
application. They've concluded that the animals who developed less 
epidural fibrosis was those with Healon application laminectomy and 
these mice presented with a reduction of post-laminectomy pain-
related behaviour.(62) 
Chitin and chitosan
Chitin is a co-polymer of N-acetyl-glucosamine and of N-glucosamine 
randomly distributed either in blocks or along the biopolymer chain, 
depending on the process method used to obtain it. When the number 
of N-acetyl-glucosamine units is superior to 50% it is called chitin and 
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when the number of N-glucosamine units is superior that biopolymer is 
then called chitosan. Of these two biopolymers, chitosan has been 
more used on research due to its prompt solubility on diluted acids 
which males this polymer more accessible for chemical reactions use. 
Chitin and chitosan are obtained from shellfish such as crabs and 
shrimps. It could be possible, on a near future, chitin or chitosan 
production through biotechnology techniques, especially if it's for 
medical applications.(63)
Since the mid-sixties that a considerable amount of chitin and 
chitosan related research comes from Asia, mainly from Japan. 
Nowadays it is globally accepted that any material, to be considered 
implantable should be of natural origin. This happens because these 
natural materials have already showed a better capacity for promoting 
cure on a higher rate and, therefore, it believes that it would show a 
better compatibility with humans. In addition, new concepts over 
medical use implantable devices, mainly on tissue engineering, points 
to a combination of a biomaterial in which cells are sown and which 
would suffer a biodegradation process into non-toxic products.(64)
Chitosan hybrids
While chitosan matrices have low mechanical strength under 
physiological conditions and are unable to maintain a predefined shape 
after transplantation, their mechanical properties can be improved by 
m o d i f i c a t i o n w i t h a s i l a n e a g e n t , n a m e l y γ -
glycidoxypropyltrimethoxysilane (GPTMS), one of the silane-coupling 
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agents which has epoxy and methoxysilane groups. The epoxy group 
reacts with the amino groups of chitosan molecules, while the 
methoxysilane groups are hydrolyzed and form silanol groups. Finally, 
the silanol groups are subjected to the construction of a siloxane 
network due to the condensation. Thus, the mechanical strength of 
chitosan can be improved by the cross-linking between chitosan, 
GPTMS and siloxane network. By adding GPTMS and employing a 
freeze-drying technique, an hybrid chitosan membrane with pores of 
about 110 µm diameter and about 90% of porosity is obtained.(65) 
A synergistic effect of a more favorable porous microstructure and 
physicochemical properties (more wettable and higher water uptake 
level) of chitosan hybrids, and the presence of silica ions may be 
responsible for the good results in promoting post-traumatic nerve 
regeneration. In fact, chitosan hybrids were successful in improving 
sciatic  nerve regeneration after axonotmesis, both isolated or using 
non-differentiated human mesenchymal stem cells.(66,67)
Significant differences in water uptake between commonly used 
chitosan and hybrid chitosan membranes were reported and it has 
been shown that they retain about two times as much biological fluid. 
The addition of GPTMS improves the wettability of chitosan surfaces. 
The improvement of the wettability of chitosan surfaces is achieved by 
the addition of GPTMS. Wettability of material surfaces is one of the 
key factors for protein adsorption, cell attachment and migration, 
which can explain, at least partially, the good results on nerve 
regeneration studies.(66,67)
Despite this factors, the significant improvement of axonal 
regeneration obtained in crushed sciatic nerves surrounded by hybrid 
chitosan membranes suggests that this material may not just work as a 
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simple mechanical scaffold but instead may work as an inducer of 
nerve regeneration. The neuroregenerative property of hybrid chitosan 
membranes might be explained by the action on Schwann cell 
proliferation, axon elongation and myelination. Yet, the expression of 
established myelin genes may be influenced by the presence of silica 
ions which exert an effect on several glycoprotein expression.(66,67)
Other studies reveals chitosan ability to promote cell membranes 
fusion after damage as chitosan is able to form large phospholipid 
aggregates by inducing the fusion of small dipalmitoyl 
phosphatidylcholine bilayers — which are major endogenous 
components of the plasma membrane. Moreover, chitosan 
preferentially targets damaged tissues.(68,69)
On the other hand, on biocompatibility studies, hybrid chitosan 
membranes elicits a mild inflammatory response (consisting of a mixed 
inflammatory infiltrate and mild peripheral fibrosis) that decreases 
gradually until the third month. This findings are in clear contrast with 
the exuberant pyogranulomatous inflammatory reaction involving 
numerous neutrophils (PMN) and macrophages surrounded by a thick, 
immature and highly vascularized fibrous capsule (granulation tissue) 
developed by non-hybrid chitosan membranes.(70)
Chitin and chitosan - Applications on Orthopaedics
An amalgam of a mineral polymer originates a composite material 
with the polymer resistance and flexibility and the mineral strength 
and hardness. Over the last few years there were generated some 
polymer and calcium composites in which the potential advantage 
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could be not only an increase of the osteogenic potential through the 
calcium component but also the inhibition of the calcium component 
migration through the polymer matrix. In example, it has been 
demonstrated that a combination of a polymer with hydroxyapatite 
maximises the hydroxyapatite osteo-conductive behaviour which 
allows bone growth inside the device as the matrix is progressively 
reabsorbed.(71)
In a study conducted by Wan et al., chitin was combined with 
hydroxyapatite producing a composite material with a strength 
reduction but maintaining the polymer plastic properties. In the same 
way, those authors worked on chitin-mediated in situ calcification 
induction using chemically modified chitin with anionic carboxymethyl 
groups, which would act as calcium attraction sites.(72) 
Ma et al. created cement with calcium phosphate and 
phosphorylated chitosan and, on rabbit models, didn't find adverse 
effects and presented histological evidence suggest ing 
biocompatibility, bio-absorption and osteo-inductivity.(73,74,75)
Many other studies were conducted using chitosan as a main 
component on calcium based cements. Most of these studies have as 
goal the development of bone replacement materials using various 
techniques for achieving a material with the desired characteristics (in 
terms of resistance, plasticity, porosity, etc.) that are thought to have 
advantage in vivo.(76)
Therefore, it appear to be natural the development of more work 
using chitin and chitosan on the production of similar compounds and 
some of which with practical application, on the short-term.
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Chitin and chitosan- Applications on Tissue Engineering
Most of tissue engineering research is based on cell sowing/culture 
on biodegradable porous polymer matrixes. The limiting element for 
those studies is the availability of good biomaterials that work as 
temporary matrixes. Therefore, these biomaterials should have the 
ability of acquiring a porous form when prepared in a way to provide a 
channel between the matrix and receptor cells that would allow the 
tissue to growth into the biomaterial while this biomaterial is 
progressively degrading on non-toxic compounds.
Khor et al. produced a series of chitin porous matrixes with 100 to 
500 um pores in wich they have verified growth and proliferation of 
human and mice fibroblasts.(77)
Many studies have been developed using chitosan combinations with 
several materials and it have been verified very appealing 
potentialities of the resulting biomaterials such as membranes without 
significative endothelial cells interaction (imunoisolating potential). 
These membranes in particular were used on tissue engineering 
research for the development of a trachea and in which chitosan was 
shown to exert a strong influence on nervous cells adherence and 
proliferation.(78)
Cho et al. prepared biomaterials combining chitosan and alginate 
and demonstrated hepatocyte adherence to those materials.(79)
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Chitin and chitosan - Applications to wound healing
Implantable chitin based biomaterials are a field of research in 
large expansion, especially on Asia. The interest is based on the fact 
that the chitin monomeric  unit, N-acetyl-glucosamine, also present on 
hyaluronic acid, is of major importance on tissue repair. Therefore, it 
has been postulated that chitin should have certain characteristics 
favourable to the promotion of fast dermal regeneration. So, efforts 
have been developed to create biomaterials that would enhance tissue 
regeneration, from simple wound covering materials to complex 
matrixes of artificial skin.
Ueno et al. demonstrated that chitosan (on a cotton form) acted as 
an accelerator on wound repair since it has an important role on 
polimorphonuclear cells infiltration in the lesion site.(80)
On an attempt to increase keratin's tension properties, Tanabe et al. 
developed a composite keratin film with 10-30% chitosan. This 
material showed as main features fibroblasts adherence and 
proliferation and bacterial resistance.(81) 
Park et al. studied the effect of modified chitin with anionic 
carboxymethyl groups on normal human fibroblast proliferation and on 
in vitro cultures of keloid fibroblasts. They have verified that this 
biomaterial inhibited the growth of keloid fibroblasts but exert no 
influence whatsoever on normal fibroblasts.(82)
Dung et al. presented good results on a three years clinical trial 
with the use of 'Vinachitin', a biomaterial with a membrane shape, for 
the treatment of near 300 patients with severe burn lesions, 
40
orthopaedic  trauma and ulcers. Results were presented on the 8th 
International Conference on Chitin and Chitosan.(83)
Chitin and chitosan - Applications on drug release formulations
Implantable chitin and chitosan applications either in the form of 
hydrogel or membrane, has been an important research field for these 
biomaterials. Several authors have been proposing chitosan as a 
component for interpenetrating networks.(84,85,86)
The creation of mucoadhesive membranes using an acrylic  acid 
polymerisation with chitosan technique was used successfully on a 
drug transmucosal release study (in this case, triamcinolone 
acetonide) for the inflammation reduction on oral ulcers treatment.(87)
Citosan microsferes and nanosferes was also created for drug 
release and chitosan based microgranules were developed for 
dissodium diclofenac release.(88) In vivo studies with chitin microsferes 
showed 60% clearance 3 hours after administration, on an animal 
model, with most microsferes to be retained in the liver suggesting 
therefore, that these microsferes could be used for selective liver 
directed drug release.
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Chitin and chitosan - Other biomedical applications
Sato et al. studied the efficiency of chitosan transfection as gene 
vehicle.(89) On other works chitosan was used to increase the 
adenovirus infectious rates to human cells on gene therapy research. 
Chitosan fibres could be used on the production of blood vessels 
because of the blood compatibility featured both by chitin and 
chitosan. This blood compatibility has been chitin and chitosan main 
characteristic since the early studies by Hirano, in 1985.(90) Recent 
publications from this author move forward to this direction. Another 
potential chitosan application is the bioadhesive materials production. 
Ishihara et al. prepared a chitosan and lactosis based material which 
they have verified to have an adhesive strength similar to fibrin glue.
Chitin and chitosan - Biocompatibility
The in vivo degradation rate has high values to chitin but it 
gradually decreases as deacethylation increases. However, it was 
described a mild reaction to chitonsan subcutaneous implants on an 
animal model.(91)
On another animal model water soluble chitosan biodegradation 
study on animal model, the authors verified that about 50% of 
deacethylated material was promptly degraded and eliminated and, 
therefore, it did not raised any bioaccumulation issues.(92) Other works 
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researched chitin and chitosan effect on biological systems. Thus, 
when chitin or chitosan are orally or intra-peritoneal administrated on 
animal models, chitosan triggers more reaction than chitin.(93)
Some studies point to a chitin mediated fibroblast proliferation 
accelerating effect while chitosan would have an inhibitory effect, 
probably due to bounding to growth factors that, otherwise, would 
bind to target sites exerting their functions. Thus, this point of view is 
polemic due to many different studies with contradictory results.(94,95)
Chitin and chitosan - Sterilisation
On the evaluation process of any biomaterial potentialities, its 
sterilisation features are an important topic to evaluate and it assumes 
a sine qua non condition when concerning implantable biomaterials. 
Thus, medical and pharmaceutical products common sterilisation 
methods, as dry heat, saturated steam, ethylene oxide and gama 
radiation, were tested on chitosan products.
Lim et al. studied the effects of dry heat, saturated steam and 
gama radiation on chitosan membranes and verified that dry heat 
exposure resulted on a decrease of chitosan water solubility and, on 
extreme cases, insolubility in acid aqueous environments. It was 
registered a 60% reduction on the tensional strength and 53% reduction 
on fracture point tension.(96,97) It was also verified that saturated 
steam significatively enhances the rate and extension of chitosan 
termal events. Chitosan became water insoluble and it loses 80% of its 
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tensional strength maintaining only 28% of its original fracture point 
tension. 
Gama radiation has produced events of chitosan main chains 
breakdown. Chitosan membranes irradiated with open air 2,5 Mrad 
presented with a 58% elevation on tensional strength and a decrease of 
22-33% on volumetric expansion capability. Performing radiation under 
anoxic conditions these membrane properties changes are considerably 
reduced.(98) It can be concluded that the best mean of sterilisation for 
chitosan products is 2,5 Mrad gamma radiation under anoxic 
conditions.
Economics of chitosan production
On the late seventies, the chitin/chitosan production costs were 
subject of interest. On those days, in the US, taking a plant capable of 
producing approximately 5×105 kg chitosan/year a spread of possible 
production costs were calculated ranging from $1.20/kg to $2.20/kg 
(chitin) and from $1.82/kg to $5.53/kg (chitosan). This gives an 
average cost of $3.50/kg, which at 2008 prices, based on the 
Consumer Price Index of the Federal Reserve Bank of Minneapolis, 
converts to $11.50/kg. However, these calculations made in 1977 were 
based on the assumption that the raw material, that is the waste from 
the shellfish processing plants, would be available at very low or even 
zero cost. This is one factor that has changed considerably and 
competition for the shellfish waste is now coming in particular from 
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animal feed stuff manufacturers, including those supplying prawn and 
shrimp farms. This conflict may become a major obstacle to increasing 
chitosan production if a large scale chitosan application was to emerge 
in the future. The use of other raw materials as waste mycelium, and 
the use of new production processes such as the electrochemical 
process, could both contribute to the overcoming of this potential 
shortage should it ever arise. Currently, the increasing chitosan 
medical applications interest inflated the chitosan production prices 
with ‘medical grade' chitosan being offered by several companies at a 
cost of approximately $25,000/kg.(99)
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Animals
For this study 14 New Zealand male rabbits were used. The animals 
average weight was 3kg. Each animal undergone two level lumbar 
laminectomy (L1 and L3). On each animal, one laminectomy site was 
randomly selected for biomaterial application and the other 
laminectomy site acted as control. The animals were kept on 
Veterinary Medical Teaching Hospital of Trás-os-Montes e Alto Douro, 
and were fed a standard rabbit regimen. All rabbits underwent a 
complete pre-operative neurological evaluation to ensure complete 
neurological integrity. After surgery, all animals were kept under close 
surveillance for infection or neurological deterioration screening. All 
procedures were performed with the approval of the Veterinary 
Authorities of Portugal in accordance with the European Communities 
Council Directive of 24 November 1986 (86/609/EEC).
Chitosan membranes preparation
Chitosan (high molecular weight, Sigma, USA) was dissolved in a 
0.25M acetic  acid solution to attain a concentration of 2% (w/v). The 
hybrid membranes were obtained by adding GPTMS (Sigma, USA) to the 
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chitosan solution. After stirring at room temperature for 1 hour, the 
resultant chitosan and chitosan-silicate solutions were poured into 
polypropylene containers with cover, and aged at 60°C for 2 days. 
After aging, the membranes were dried at 60°C for 2 days. The 
chitosan and chitosan-gama-glycidoxypropyltrimethoxysilane 
membranes were soaked in a 0.25M  sodium hydroxide solution to 
neutralize the remaining acetic acid, and then washed with distilled 
water, and dried at 37°C for 24 hours. Before the implantation 
procedure the membranes were sterilized with ethylene oxide gas and 
kept at room temperature for 1 week (Figure 1).
Figure 1: Implantable chitosan membrane.
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Surgical procedure
Animals were anesthetized intravenously with ketamine (30 mg/kg) 
and medetomidine (0.1 mg/kg). Then, lateral spine radiographs were 
performed in order to identify the number of lumbar vertebrae and, 
thus, localize the segments to operate.
A midline incision exposed the spinal column at the L1–L3 level, and 
the paravertebral muscles were dissected bilaterally to visualize the 
transverse apophyses.
The segments to approach were identified intra-operatively by 
direct palpation. On each segment, the dorso-lumbar fascia was 
divided and a bilateral paravertebral muscles subperiosteal dissection 
was performed. On this stage, the paravertebral muscles were 
retracted using a retractor (Figures 2 and 3). It was then performed 
the bilateral laminectomy at L1 and L3 with a drill until dura-mater 
exposure (Figure 4).
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Figure 2: Surgical procedure images: (A) Midline skin incision at L1-L3 level, after 
spine localization plain radiograph and tricotomy; (B) Division of the dorso-lumbar 
fascia on each side of the spinous processes; (C) Bilateral subperiosteal dissection of 
the paravertebral muscles.
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The laminectomy defects were measured to be approximately 
10x5mm.
In order to diminish the influence of any level-specific  variations the 
biomaterial implantation was placed on L1 laminectomy site (7 
animals) and on L3 laminectomy site (7 animals), the defect was left 
empty in the other sites.
Care was taken in order to make a chitosan membrane adapted to 
the bone defect dimensions in a way that it covered the totality of the 
defect and also the bone of the margins (Figure 5). A thorough 
hemostasis was performed in order to reduce the potential post-
operative haematoma. Dorso-lumbar fascia was closed with simple 
stitches of resorbable suture and the cutaneous layer was closed with 
intra-dermic continuous resorbable suture. The operative wound was 
cleaned with an iodopovidone solution.
During the procedure the animal’s temperature, blood pressure and 
electrocardiogram were continuing screened. An ophthalmic  gel 
(Lacryvisc, Alcon, Lisbon, Portugal) was applied to prevent drying of 
the eyes.
Postoperatively the animals were housed in individual cages and 
allowed normal activity. They were weighed daily for the first 7 days 
postsurgery and then weighed weekly. Postoperative care included 
injections of sulfadiazine and trimethoprim twice a day for up to 1 
week. 
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Figure 3: Posterior aspect of the lumbar vertebra after finishing paravertebral 
muscles dissection.
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Figure 4: Surgical procedure images: (A) Spinous process removal with bone 
roungeur; (B) Laminectomy performed with high-speed drill; (C) Bone removal from 
the laminectomy borders with bone rongeur.
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Figure 5: Surgical procedure images: (A) Laminectomy final aspect with visualization 
of blood vessel throught the thin lumbar dura; (B) Chitosan membrane over the 
laminectomy site covering all the laminectomy area and its bone borders.
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Histological analysis
The animals were euthanised 4 weeks after laminectomy.
The vertebral L1-S1 segment was removed en bloc during the 
animals necropsy and was fixed on 10% formaldehyde. Decalcification 
of the entire vertebral segment was achieved using the Morse solution. 
In brief, decalcification was obtained using sodium citrate/formic acid 
until chemical testing for the presence of calcium runs negative; the 
samples were placed in ten times their volume of the decalcifying 
solution and the solution was replaced daily. Chemical testing of the 
presence of calcium was carried out by adding 1cc of ammonium 
hydroxide to 5 cc of the decalcifying solution plus 0,1cc of a saturated 
ammonium oxalate solution. When calcium is still present in the 
solution, it precipitates, otherwise decalcification is complete (usually 
it takes around three weeks).
The columns were then cut in 1-cm-long segments transversely to 
their axis. Each column was then rehydrated with PBS and cryo-
protected with three passages in increasing solutions of sucrose (7.5% 
for 1 hr, 15% for 1hr, 30% over-night) in 0.1M  PBS. Thereafter, 
specimens are maintained in a 1:1 solution of sucrose 30% and optimal 
cutting temperature medium (OCT) for 30 min and then embedded in 
100% OCT. Specimens must then be store at –80°C.
Sections were then cut by means of a Leica CM1850 Cryostat in a 
thickness range of 20-30 µm, placed on silane-coated microscope slides 
to improve slice adhesion, and stored at –20°C. Before staining, 
sections were taken out of freezer to room temperature and as soon as 
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they were acclimatized, they were further processed either by 
haematoxylin and eosin (the most commonly used stain for light 
microscopy observation in histology and histopathology) or by Masson’s 
trichrome staining (that, in comparison to haematoxylin and eosin 
staining, it highlights also connective tissue).
For haematoxylin and eosin staining, the slides were immersed in 
0.1% haematoxylin (we use the product from Ciba, Basle, Switzerland) 
for 10 min, washed in tap water for 15 min, then immersed in 0.1% 
eosin (we use the product from Ciba, Basle, Switzerland) for 5 min and 
washed in distilled water. The sections were finally dehydrated in 
ethanol and mounted in DPX (Fluka, Buchs, Switzerland).
For Masson’s trichrome staining, we used a Masson trichrome with 
aniline blue kit (Bio-Optica, Milano, Italy): six drops of Weigert’s iron 
haematoxylin (solution A) and six drops of Weigert’s iron haematoxylin 
(solution B) were combined together and used to stain slides for 10 
min. Without washing, the slides were then drained and incubated 
with ten drops of alcoholic picric  acid solution for 4 min. After washing 
in distilled water, sections were stained with ten drops of Ponceau acid 
fuchsin for 4 min and washed again in distilled water. Further on, ten 
drops of phosphomolybdic acid solution were added to the section for 
10 min. Without washing, the slides were drained and 10 drops of 
aniline blue are added to the section for 5 min. Finally, after washing 
in distilled water, dehydrating rapidly in ethanol and clearing in xylol/
Bioclear (Bio-Optica, Milano, Italy), the slides were mounted in DPX 
(Fluka, Buchs, Switzerland). 
Sections were then analyised and photographed suing a DM4000B 
microscope equipped with a DFC320 digital camera and an IM50 image 
manager system (Leica Microsystems, Wetzlar, Germany).
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Results of the histological analysis of rabbit columns at the site of 
laminectomy are illustrated in figures 6-9.
Extensive microscope observations, at different magnifications, 
showed, in the animals that did not receive chitosan application, the 
presence of a disorganized regenerating tissue (fig. 6A, asterisk) 
mingled with islets of bone tissue (fig. 6A, arrows). At higher 
magnification (fig. 6B), the regenerating tissue appeared to be rich in 
various-sized and round-shaped cells (including many lymphocytes) 
that indicate the persistence of a chronic  inflammatory condition. 
With respect to the bone tissue organization at the border of the 
lesion site, lamellae did not show osteonic organization and were 
oriented without clear orientation (fig. 7A). Higher magnification 
observation (fig. 7B) showed that the interface between the 
regenerating tissue and the bone tissue (fig. 7B, arrow) has a limited 
extension without a clear orientation. Often, bone and regenerating 
tissue were completely detached and separated by large empty 
lacunae (fig. 7A, asterisk).
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Figure 6: (see text for details)
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Figure 7: (see text for details)
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Figure 8: (see text for details)
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Figure 9: (see text for details)
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Histological analysis of rabbit columns at the site of laminectomy in 
the animals that received chitosan application is illustrated in figures 8 
and 9. 
At lower magnification (fig.8), the presence of a well-organized 
regenerating tissue, integrated in the surrounding vertebral bone 
tissue though an interface (fig. 8A-B, arrows) that, contrary to what 
observed in the control group, was regular and extended from on side 
to the other side of the lamina. Although the location of islets of bone 
tissue inside regenerating tissue (fig. 8C-D) and the small extension of 
regenerative tissue in comparison to controls suggest that bone 
regeneration has progressed significantly filling the lamina defect. Yet 
the presence signs of osteonic reorganization (fig. 9A-B, asterisk) can 
be detected inside the regenerating tissue. However, since 
regenerated bone tissue can hardly be distinguished from native bone 
tissue, the amount of regenerated bone cannot be quantified. 
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Since the clarification of the sciatic pain pathophysiology, nearly a 
century ago, and its relationship to lumbar disk herniation, several 
surgical approaches were proposed. The surgical approach currently 
and wide-world used has its origin in the works of Yasargil and Caspar 
on the mid-seventies.(4,6) Currently it's the most common neurosurgical 
procedure performed in the US and there is evidence that the surgical 
treatment has advantage over conservative treatment.(4,17) The 
surgical technique involves a posterior approach through a small skin 
incision and an extradural disk removal. Several authors have 
descriptions of their technique and a large majority describe gestures 
for protection against post-operative scarring such as removal of the 
ligamentum flavum bone insertions after its excision, preservation of 
the medial portion of the ligamentum flavum or complete preservation 
and performing only a division of the ligament to access the vertebral 
canal, preservation of the epidural fat layer or application of fat grafts 
or steroids over the bone defect.(1,2,6,8,9) The prevention of post-
operative perineural fibrosis has been object of increasing interest as 
this condition has been pointed out as one of the main causes of Failed 
Back Surgery Syndrome. Although the aetiology of this syndrome is not 
fully understand, post-operative perineural fibrosis is commonly 
pointed as an important etiopathogenic factor.(18,20,21) The 1996 
prospective, randomized, controlled, blind and multicentric trial, 
presented by Ross et al. revealed a significative association between 
post-operative epidural fibrosis and recurrent radicular pain.(23)
The epidural fibrosis formation is the result of post-operative 
hematoma invasion by thick fibrotic tissue, starting on the periosteum 
fibrous layer and fibroblast migration from the deep layer of the 
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paravertebral muscles. This process can progress to the vertebral canal 
and create adherences to the dura-mater and nerve roots.(27,28) Wound 
healing consists of three phases: (1) the inflammatory phase, which 
consists of inflammatory cell migration to the healing wound; (2) the 
proliferative phase, which consists of new tissue formation such as 
angiogenesis, fibroplasia, epithelialization, and extra-cellular matrix 
accumulation; and (3) the tissue remodeling, which is the maturational 
phase.(100)
Fibroblasts, which invade the wound in the first few days of healing, 
have multiple functions important to wound repair, such as collagen 
synthesis,  extracellular matrix reorganization, and wound contraction 
resulting in mature scar formation. It has been shown that chitosan 
can inhibit fibroblast growth.(101,102)
Chang et al. in a study for reduction of peritoneal adhesions using a 
Electrospun anti-adhesion barrier made of chitosan concluded that this 
later component can inhibit tissue adhesion by inhibiting proliferation 
and triggering apoptosis.(102) Apoptosis as a programmed, physiological 
mode of cell death that plays a key role in tissue homeostasis may be 
inhibited by deleterious stimuli such as hypoxia, contorting the 
balance of cellular proliferation, differentiation, and death, hence 
impairing the normal peritoneal wound repair process.(103) The results 
of the study by Chang et al. suggested that in the presence of 
chitosan, apoptosis would occur in a significant level. Previous studies 
reported that chitosan may interact with the cell membrane to trigger 
apoptosis.(104,106) N,O-carboxymethyl chitosan (NOCC) is a non-toxic 
absorbable agent that is also used to prevent postoperative adhesion 
formation. This agent is used as a peritoneal instillate and is suggested 
that, in addition to its mechanical action in separation of raw 
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peritoneal surfaces, it dilutes fibrin and fibrinous exudate released 
from traumatized tissue.(105)
On recent study evaluating the effectiveness of biophysical barriers 
on peridural fibrosis, Kasimcan et al. compared ADCON-L and 
Seprafilm® Adhesion Barrier on an animal model. ADCON-L is a 
bioresorbable carbohydrate polymer gel which is composed of a 
polyglycan ester and porcine derived gelatin in phosphate-buffered 
saline. It is suggested to prevent scar formation when it is applied on 
nervous structures. It is an antiadhesive and physical barrier gel that 
prevents fibroblastic  migration in the laminectomy area. Seprafilm® 
Adhesion Barrier is a bioresorbable adhesion membrane composed of 
two an ion i c po ly sacchar ides , sod ium hya lu ronate and 
carboxymethylcellulose. It is indicated in patients undergoing 
abdominal or pelvic laparotomy as an adjunct intended to reduce the 
incidence, extent and severity of postoperative adhesions between the 
abdominal wall and the underlying viscera. The authors observed low 
level density of peridural adhesion on both experimental groups 
however, the fibroblast count results were not found statistically 
different between experimental groups and controls. The authors 
postulate that although these barriers are almost physiologically inert 
materials, they are also physiologic bioresorbable and they are 
removed by macrophages which can also transform and behave as 
fibroblast. These materials may act as foreign bodies, and force the 
macrophages and histiocytes to migrate into the laminectomy area in 
long term period. So it's suggested that these materials could not block 
the inflammatory cell migration into the laminectomy area of the rat.
(106)
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For this study it was used an animal laminectomy model using New 
Zealand rabbits. The bone anatomy of these animals is favourable for a 
lumbar laminectomy model as the dorsal laminae are long which 
makes the surgical procedure brief and straightforward, therefore 
reducing post-operative complications. One of the major complications 
of this procedure in rabbits is post-operative neurological deterioration 
which is more common with laminectomies on lower levels. This fact 
determined the choice of the laminectomy level for this work. Thus, 
two level lumbar laminectomy were performed, on L1 and L3. At these 
levels, on the vertebral canal, there is the lower portion of the spinal 
cord. Therefore, on this particular aspect, this model does not mimic 
the human lumbar laminectomy conditions. For these concerns, some 
authors have suggested lumbar laminectomy models in the region of 
the cauda equina (suggesting different animals, such as the ovine 
model) which would allow biomechanical testing on nerve roots.(53,57) 
However, on the present work, the focus of the study was the 
histological characterization of the differences of post-operative 
fibrosis on a manipulated site (in the presence of the biomaterial) and 
on a control site. So, the results are still valid and applicable to the 
biomaterial effects on post-operative epidural fibrosis.
Another pitfall of the present study is that a simple laminectomy 
was performed to the rabbits and a discectomy was not done. So, the 
effect that the experimental material might have on scar formation at 
discectomy site and on anular ligament healing could not be assessed. 
This was not done because of the extreme difficulty to expose the 
nerve root and annulus fibrous without neurologic injury in a rabbit 
model.
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Chitosan matrices have been shown to have low mechanical strength 
under physiological conditions and to be unable to maintain a 
predefined shape for transplantation. The improvement of their 
mechanical properties can be achieved by modifying chitosan with a 
silane agent. The gama-glycidoxypropyltrimethoxysilane (GPTMS) is 
one of the silane-coupling agents, which has epoxy and methoxysilane 
groups. The epoxy group reacts with the amino groups of chitosan 
molecules while the methoxysilane groups are hydrolyzed and form 
silanol groups. The silanol groups are subjected to the construction of 
a siloxane network due to the condensation. Thus, the mechanical 
strength of chitosan can be improved by the crosslinking between 
chitosan, GPTMS and siloxane network.(66,67) This chitosan membrane 
was used on the present work and was found to be very convenient to 
manipulate in order to cover the entire bone defect.
One important aspect of this study results was the finding that the 
chitosan membrane were consistently and totally degraded by the 
fourth week after the surgical procedure. This is an important feature 
as the barrier-effect for this biomaterial is important only in the early 
stages of the scarring process. Zhou et al. stressed this aspect on their 
work on reduction of post-surgical adhesion formation after cardiac 
surgery by application of N,O-carboxymethyl chitosan. Those authors 
described that the chitosan film used was effective on reducing post-
surgical adhesion formation maintaining its structural integrity for five 
days and degrading by the seventh post-operative day.(107)
The results of this study clearly demonstrated that chitosan had an 
organizing effect on post-operative scarring process. The presence of 
the chitosan membrane resulted on a well-organized tissue integrated 
in the surrounding vertebral bone tissue. It was also observed signs of 
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regenerative bone tissue in continuity with native bone which, by the 
present technique cannot be distinguished from each other. In fact, 
the four-week duration of this study allows only the important 
conclusion of improved vertebral regeneration on a post-laminectomy 
model. This can be a major feature on the dynamics of epidural 
fibrosis formation.
Sandoval-Sánchez et al. achieved similar results using a bilayer 
chitosan scaffolding as a dural substitute on experimental models. On 
their work it was observed the biomaterial adapted to the defect and 
attached to the host tissue borders with organized collagen fiber 
deposits and neovascularization and with no evidence of fibrosis or 
abnormal healing or epidural or subdural adhesions.(108)
Chuang et al., using a combination of poly-lactic  acid gel and 
autologous micromorselized bone observed significant lamina bone 
regeneration.(109) However it is still unknown if the regenerated 
vertebral lamina can be expected to confer stability to the spinal 
column and prevent peridural adhesion as a long-term outcome. 
Further research on ligament structure will confirm whether a newly 
generated vertebral lamina can provide an attached bed for soft tissue 
growth and enable ligament regeneration.
Nonetheless, these studies are aiming tissue regeneration after 
surgical aggression which is significantly different from other current 
studies that purely aim inhibition of fibrosis such as the use of 
mitomicin C.(100,110) Those studies, chasing the same goal, use an 
entirely different approach and their results cannot be compared with 
results from studies using regenerative approaches.
Therefore, these very interesting results open a wide gamut of 
possible future studies. It would be important to evaluate the 
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evolution over time of post-operative scarring using a chitosan 
membrane in order to access the maintenance of a well-organized 
regeneration tissue throughout the scarring process without the 
formation of perineural adhesions or formation of aberrant structures 
mainly inside de vertebral canal. These studies should use models that 
allow laminectomy procedures on the cauda equina lumbar levels. 
There should be used models to quantify the regenerated tissue 
formation and inflammatory markers survey would be of interest.
This studies would be an important contribution for giving substrate 
to human clinical trials. The transition from these studies to human 
trials poses a complex challenge. Despite the promising results 
obtained, the ideal chitosan-based material is not entirely defined as 
it's clear for the numerous studies using different chitosan-based 
formulations. The U.S. National Institutes of Health service 
ClinicalTrials.gov is a registry and results  database of federally and 
privately supported clinical trials conducted in the United States and 
around the world. A search for 'chitosan' on this database (on January, 
2012) retrieve 20 studies, from which only one involved an implantable 
chitosan-based biomaterial. This study, focusing joint cartilage 
regeneration and entitled 'Trial Comparing BST-CarGel and 
Microfracture in Repair of Articular Cartilage Lesions in the Knee' is 
designed for clinical testing of a chitosan-based biomaterial called 
BST-CarGel which was developed to stabilize the blood clot in the 
cartilage lesion by dispersing a soluble and adhesive polymer scaffold 
containing chitosan throughout uncoagulated whole blood. The 
efficacy and underlying mechanisms of action of BST-CarGel have been 
examined in several studies using animal models.(111,112) After 
promising results on animal studies, thirty-three human subjects were 
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treated with BST-CarGel from August 2003 to December 2004 under 
Health Canada's Special Access Program for medical devices that is 
designed to enable compassionate use. Notably, treatment occurred on 
a case-by-case basis and, by law, was not considered a clinical study. 
In particular, the absence of a control group as well as the wide 
ranging characteristics of the treated patients and lesions impeded a 
rigorous interpretation of outcomes. The safety of treatment with BST-
CarGel was demonstrated because no uncharacteristic observations 
were made during physical examinations or blood analyses for all 
patients. BST-CarGel has not been approved at this time for sale in any 
country. Another implantable chitosan biomaterial has been tested in 
humans on cancer therapy research. Transarterial and percutaneous 
Holmium-166/chitosan (Milican, Dong Wha Pharmaceutical Co., Seoul, 
Korea) complex was evaluated for long-term therapeutic efficacy and 
safety on clinical trials in a group of patients with hepatocellular 
carcinoma. The chitosan-based biomaterial used by the authors 
possessed the useful property of transforming from a liquid to a gel 
state depending on the pH of the surrounding environment. It was 
readily dissolved in water to yield a clear solution under acidic 
conditions but was converted to the gel state under neutral or basic 
conditions above pH 6, such as those found in injected tumor tissues, 
thus effectively holding the bound holmium in place.(113,114)
A commercially available chitosan-based based implantable 
biomaterial is the OPTOMESH(TM) (Tricomed S.A., Poland) which is a 
non-resorbable surgical mesh covered by a microporous resorbable 
chitosan coating. This mesh was designed to be used for surgical 
abdominal wall repair after hernia surgery.(114) Recent studies on 
animal models suggest that these meshes are equal, in terms of quality 
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and anti-adhesion properties, to the globally recognized Dynamesh®-
IPOM mesh.
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Whereas a quantitative analysis of the type or tissue repair was not 
possible due to its polymorph complexity, extensive microscopy 
observation carried out in the present study allowed to show that the 
morphology of tissue repair was rather consistent, in each of the two 
experimental groups, and rather differentiated between them.
It can thus be concluded that chitosan application after 
laminectomy improves vertebral regeneration by stimulating the 
formation of a new and well organised cover tissue at the site of bone 
removal.
Moreover, it promotes its quick differentiation into a newly formed 
and well organised bone tissue that integrates rapidly with the native 
bone, filling the defect and recreating a vertebral structure which is 
close to the normal pre-lesion one.
Unlike previous studies focused on inhibition of the scarring process 
in order to prevent epidural adhesions, the present work using this 
chitosan membrane, has showed that the scarring process can be 
directed to improving tissue regeneration suggesting a reduction on 
epidural fibrosis.
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